Studies of Structure-Activity Relations of Complement Inhibitor Compstatin.

Journal of Immunology - United States
doi 10.4049/jimmunol.172.8.5128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Compstatin: A Complement Inhibitor on Its Way to Clinical Application

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2008English

New Analogs of the Complement C3 Inhibitor Compstatin With Increased Solubility and Improved Pharmacokinetic Profile

English

Structure-Activity Relationship Studies of the Natural Product Gq/11 Protein Inhibitor YM-254890

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

The Structural Basis of Compstatin Activity Examined by Structure-Function-Based Design of Peptide Analogs and NMR

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)

PLoS ONE
Multidisciplinary
2017English

Synthesis and Structure–activity Relationship Studies on Tryprostatin A, an Inhibitor of Breast Cancer Resistance Protein

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2008English

Cover Picture: Conjugation to Albumin-Binding Molecule Tags as a Strategy to Improve Both Efficacy and Pharmacokinetic Properties of the Complement Inhibitor Compstatin (ChemMedChem 10/2014)

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2014English

Structure-Activity Relations: Maximizing the Usefulness of Mutagenicity and Carcinogenicity Databases

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1991English

Synthesis, Crystal Structure, Structure-Activity Relationships, and Antiviral Activity of a Potent SARS Coronavirus 3CL Protease Inhibitor

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy